Increased in number of surgical procedures across the world, large pool of geriatric population and thus prevalence of chronic diseases, and benefits of coated endotracheal tube are expected to propel the growth of the global coated endotracheal tube industry.
According to the report published by Allied Market Research, the global coated endotracheal tube market accounted for $1.63 billion in 2016 and is projected to garner $2.52 billion by 2023, registering a CAGR of 6.3% from 2017 to 2023.
Increased in number of surgical procedures across the world, large pool of geriatric population and thus prevalence of chronic diseases, and benefits of coated endotracheal tube have boosted the global coated endotracheal tube market. However, dearth of skilled professionals and post-operative risks associated with laparoscopy surgeries hamper the market growth. On the contrary, emerging economies and technologies advancement in endotracheal tubes are expected to create lucrative opportunities in the near future.
Download Sample Copy of this Report @ https://www.alliedmarketresearch.com/request-sample/3622
The global coated endotracheal tube market is divided into intubation, application, end user, and geography. Based on intubation, the market is segmented into orotracheal and nasotracheal intubation. The orotracheal intubation segment held the largest share in 2016, accounting for two-thirds of the market, owing to increased usage, applicability, and comfortability. However, the nasotracheal intubation segment is projected to register the fastest CAGR from 2017 to 2023.
On the basis of application, the market is bifurcated into anesthesia, emergency medicine, and others. The emergency medicine segment is estimated to manifest the fastest CAGR during the forecast period, owing to rise in incidence of various type of trauma injuries and road accidents. Moreover, the segment held more than two-fifths of the market.
Based on end user, the market is categorized into hospital, clinics, and ambulatory surgical centers [ASCs]. The ambulatory surgical centers segment is projected to portray the fastest CAGR of 5.6% during the period 2017–2023.
The global coated endotracheal tube market is analyzed across various regions such as North America, Europe, Asia-Pacific, and LAMEA. The market across North America held the lion’s share in 2016, contributing two-fifths of the market, owing to early approval of endotracheal tubes and increased used of these tubes due to prevalence of chronic diseases. However, the market across Asia-Pacific region is projected to reach the fastest CAGR of 7.3% during the forecast period, due to rise in affordability, increase in healthcare expenditure coupled with rise in awareness toward coated endotracheal tubes.
The market report includes in-depth analysis of the major market players such as Bactiguard Holding AB, C.R. Bard, Hospiteknik Healthcare, Enox Biopharma Inc., N8 Medical, LLC, Innovative Surface Technologies, Sonoma Pharmaceuticals, Inc., Sharklet Technologies, Inc., Teleflex Incorporated, and Venner Medical International.
Read More @ https://www.alliedmarketresearch.com/press-release/drug-coated-endotracheal-tube-market.html
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com
